Solid Biosciences Inc
SLDB
Get informed when a big investor buys or sells
+ FollowMarket Cap$610.04M
Close$
$0.44
94.3% downside
Current Fair Value
94.3% downsideOvervalued by 94.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $610.04 Million |
|---|---|
| Enterprise Value | $332.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.99 |
| Beta | 2.36 |
| Outstanding Shares | 109,811,461 |
Return
| Return on Equity | -51.26% |
|---|---|
| Return on Assets | -45.35% |
| Return on Invested Capital | -50.14% |
Valuation & Multiples
| P/E Ratio | -4.02 |
|---|---|
| PEG | -9.04 |
| Price to Sales | - |
| Price to Book Ratio | 2.61 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.69 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 47.33% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.15%▼ 105.10% |
|---|---|
| Total Invested | $1.63M▼ 99.77% |
| Investors Holding | 14▼ 135.00% |
ESG Score
No data